1. Home
  2. LRMR vs LFMD Comparison

LRMR vs LFMD Comparison

Compare LRMR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.56

Market Cap

332.1M

Sector

Health Care

ML Signal

HOLD

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.81

Market Cap

330.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRMR
LFMD
Founded
N/A
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.1M
330.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LRMR
LFMD
Price
$3.56
$3.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$16.71
$10.22
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
11-05-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$250,091,814.00
Revenue This Year
N/A
$21.50
Revenue Next Year
N/A
$17.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
28.78
52 Week Low
$1.61
$3.43
52 Week High
$6.91
$15.84

Technical Indicators

Market Signals
Indicator
LRMR
LFMD
Relative Strength Index (RSI) 46.32 24.14
Support Level $3.32 $3.78
Resistance Level $3.79 $4.06
Average True Range (ATR) 0.24 0.30
MACD 0.04 -0.05
Stochastic Oscillator 58.77 19.16

Price Performance

Historical Comparison
LRMR
LFMD

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Share on Social Networks: